Infantile hemangiomas: a 7-year experience of a single-center.

Clujul medical (1957) Pub Date : 2017-01-01 Epub Date: 2017-10-20 DOI:10.15386/cjmed-781
Mădălina Bota, Gheorghe Popa, Cristina Lucia Blag, Daniel-Corneliu Leucuta, Alexandru Tătaru
{"title":"Infantile hemangiomas: a 7-year experience of a single-center.","authors":"Mădălina Bota,&nbsp;Gheorghe Popa,&nbsp;Cristina Lucia Blag,&nbsp;Daniel-Corneliu Leucuta,&nbsp;Alexandru Tătaru","doi":"10.15386/cjmed-781","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of the study was to describe the historical and clinical characteristics of hemangiomas in a series of cases of our clinic.</p><p><strong>Methods: </strong>This is a retrospective study of 36 patients with infantile hemangiomas consulted in our clinic.</p><p><strong>Results: </strong>We had 14 multiple hemangiomas, and 1 kaposiform hemangioendothelioma. Almost two-thirds involved the cephalic extremity, and 76% of the cases were treated. Pregnancy risk factors included prematurity, low-birth weight and respiratory distress syndrome. Propranolol was used in 22 cases, followed by prednisone in 3 cases. Vincristine and interferon were used as associated therapies or as second line therapies. Two hemangiomas had complications, one ulceration and a Kasabach-Merritt syndrome. All the patients had a good evolution.</p><p><strong>Conclusions: </strong>Our study results regarding the involvement of pregnancy and birth risk factors in developing infantile hemangiomas is similar to literature data. The majority of patients had at least one risk factor suggesting that at least one trigger to develop an infantile hemangioma is necessary. Our study shows that the cephalic extremity is mostly involved, and because of its potential complications they are most likely to be treated. The study shows that propranolol is the leading treatment option with few and mild side effects.</p>","PeriodicalId":91233,"journal":{"name":"Clujul medical (1957)","volume":"90 4","pages":"396-400"},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/de/d5/cm-90-396.PMC5683828.pdf","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clujul medical (1957)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15386/cjmed-781","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/10/20 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Objectives: The aim of the study was to describe the historical and clinical characteristics of hemangiomas in a series of cases of our clinic.

Methods: This is a retrospective study of 36 patients with infantile hemangiomas consulted in our clinic.

Results: We had 14 multiple hemangiomas, and 1 kaposiform hemangioendothelioma. Almost two-thirds involved the cephalic extremity, and 76% of the cases were treated. Pregnancy risk factors included prematurity, low-birth weight and respiratory distress syndrome. Propranolol was used in 22 cases, followed by prednisone in 3 cases. Vincristine and interferon were used as associated therapies or as second line therapies. Two hemangiomas had complications, one ulceration and a Kasabach-Merritt syndrome. All the patients had a good evolution.

Conclusions: Our study results regarding the involvement of pregnancy and birth risk factors in developing infantile hemangiomas is similar to literature data. The majority of patients had at least one risk factor suggesting that at least one trigger to develop an infantile hemangioma is necessary. Our study shows that the cephalic extremity is mostly involved, and because of its potential complications they are most likely to be treated. The study shows that propranolol is the leading treatment option with few and mild side effects.

Abstract Image

Abstract Image

婴儿血管瘤:7年的单中心经验。
目的:本研究的目的是描述我们诊所的一系列病例中血管瘤的历史和临床特征。方法:回顾性分析我院36例婴幼儿血管瘤患者的临床资料。结果:多发血管瘤14例,卡样血管内皮瘤1例。近三分之二的病例涉及头端,76%的病例得到了治疗。妊娠危险因素包括早产、低出生体重和呼吸窘迫综合征。应用心得安22例,强的松3例。长春新碱和干扰素作为联合治疗或二线治疗。两个血管瘤有并发症,一个溃疡和一个卡萨巴赫-梅里特综合征。所有患者均有良好的进展。结论:我们关于妊娠和出生危险因素参与婴儿血管瘤发生的研究结果与文献资料相似。大多数患者至少有一种危险因素,这表明至少有一种诱发婴儿血管瘤的因素是必要的。我们的研究表明,主要累及的是头端,由于其潜在的并发症,他们最有可能得到治疗。研究表明,心得安是主要的治疗选择,副作用少且轻微。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信